prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Basal, PATIENT HISTORY: The patient is a -year-oid female with no clinical history or LMP given. PRE-OP DIAGNOSIS: Right breast CA. POST-OP DIAGNOSIS: Same. PROCEDURE: Right segmental mastéctomy, sentinel node. ADDENDA: Addendum. ESTROGEN/PROGESTERONE AND HER-2/NEU REPORT. Using appropriate positive and negative controis, the test for the presence of these hormone receptor proteins is. performed by the immunoperoxidase method. and reported according to the. consensus statement on adjuvant. therapy for breast cancer, of,. A positive ER or PR tumor shows any nuclear immunostaining, and is. semiquantitated as indicated below. Semiquantitative Statement. ER negative. Percent cells staining as: (0 100%). PR negative. Percent cells staining as: (0 100%). HER-2/NEU DAKO HERCEPTEST: A WEAK TO MODERATE COMPLETE MEMBRANE STAINING IS OBSERVED IN MORE. THAN 10% OF THE TUMOR CELLS. HER-2/NEU IS INTERPRETED AS WEAKLY POSITIVE (SCORE 2+). NOTE: Her-2/Neu FISH was ordered and will be subsequently reported. The Her-2/neu and estrogeniprogesterone receptor assays were performed with FDA approved. methods. FINAL DIAGNOSIS: PART 1: BREAST, RIGHT, SEGMENTAL MASTECTOMY -. A. INFILTRATING DUCTAL CARCINOMA, 3.1 CM, POORLY DIFFERENTIATED, NOTTINGHAM SCORE - 9/9. (TUBULES = 3, NUCLEAR GRADE = 3, MITOSES = 3). B. LYMPHOVASCULAR INVASION IS IDENTIFIED. C. SEPARATE FOCI OF DUCTAL CARCINOMA IN SITU, SOLID TYPE, HIGH NUCLEAR GRADE. D. THE DUCTAL CARCINOMA IN SITU EXTENDS CLOSE (<0.1CM) TO THE POSTERIOR SURGICAL MARGIN. OF RECECTION. E. ALL SURGICAL MARGINS OF RESECTION ARE FREE OF TUMOR. F. NON-NEOPLASTIC BREAST WITH FIBROCYTIC CHANGES. PART 2: SENTINEL LYMPH NODE #1, RIGHT AXILLA, BIOPSY -. ONE (1) LYMPH NODE, NEGATIVE FOR TUMOR (0/1), (see comment). PART 3: SENTINEL LYMPH NODE #2, RIGHT AXILLA, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR TUMOR, (0/1), (see comment). PART 4: NON-SENTINEL LYMPH NODE, RIGHT AXILLA, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR TUMOR, (0/1). COMMENT: Cytokeratin (AE1/3) stains have been performed and confirm the negative status of the sentinal lymph nodes.

expanded version (tokens=1079) : 
 Histological Classification: Infiltrating ductal carcinoma, 3.1 cm, poorly differentiated, Nottingham Score - 9/9. Separate foci of ductal carcinoma in situ, solid type, high nuclear grade.

Subtype: Basal

Necrosis: No mention of necrosis in the report.

Tumor Infiltrating Lymphocytes: There is no mention of tumor infiltrating lymphocytes in the report.

Histological Grade: Poorly differentiated, Nottingham Score - 9/9. (Tubules = 3, Nuclear Grade = 3, Mitoses = 3)

Nuclear Grade: High nuclear grade in ductal carcinoma in situ.

Lymphovascular Invasion: Lymphovascular invasion is identified.

Calcification: No mention of calcification in the report.

Receptor Status: ER/PR positive (semiquantitated percentage not mentioned in the report), HER-2/neu weakly positive (score 2+). Her-2/neu FISH was ordered and will be reported subsequently.

IHC and ancillary testing results: Cytokeratin (AE1/3) stains performed and confirm the negative status of the sentinel lymph nodes.

Other Points: The patient's pre-op and post-op diagnosis was right breast cancer, and right segmental mastectomy with sentinel node biopsy was performed. All surgical margins of resection were free of tumor, and non-neoplastic breast with fibrocytic changes was seen.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1227) : 
 Histological subtype of the right breast cancer is basal. Infiltrating ductal carcinoma, 3.1 cm, poorly differentiated, Nottingham Score - 9/9 is identified with separate foci of ductal carcinoma in situ, solid type, high nuclear grade. ER/PR status is positive and HER-2/neu score is 2+. Lymphovascular invasion is there but no tumor in the sentinel and non-sentinel lymph nodes. All surgical margins are free of tumor.

prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Basal, PATIENT HISTORY: The patient is a -year-oid female with no clinical history or LMP given. PRE-OP DIAGNOSIS: Right breast CA. POST-OP DIAGNOSIS: Same. PROCEDURE: Right segmental mastéctomy, sentinel node. ADDENDA: Addendum. ESTROGEN/PROGESTERONE AND HER-2/NEU REPORT. Using appropriate positive and negative controis, the test for the presence of these hormone receptor proteins is. performed by the immunoperoxidase method. and reported according to the. consensus statement on adjuvant. therapy for breast cancer, of,. A positive ER or PR tumor shows any nuclear immunostaining, and is. semiquantitated as indicated below. Semiquantitative Statement. ER negative. Percent cells staining as: (0 100%). PR negative. Percent cells staining as: (0 100%). HER-2/NEU DAKO HERCEPTEST: A WEAK TO MODERATE COMPLETE MEMBRANE STAINING IS OBSERVED IN MORE. THAN 10% OF THE TUMOR CELLS. HER-2/NEU IS INTERPRETED AS WEAKLY POSITIVE (SCORE 2+). NOTE: Her-2/Neu FISH was ordered and will be subsequently reported. The Her-2/neu and estrogeniprogesterone receptor assays were performed with FDA approved. methods. FINAL DIAGNOSIS: PART 1: BREAST, RIGHT, SEGMENTAL MASTECTOMY -. A. INFILTRATING DUCTAL CARCINOMA, 3.1 CM, POORLY DIFFERENTIATED, NOTTINGHAM SCORE - 9/9. (TUBULES = 3, NUCLEAR GRADE = 3, MITOSES = 3). B. LYMPHOVASCULAR INVASION IS IDENTIFIED. C. SEPARATE FOCI OF DUCTAL CARCINOMA IN SITU, SOLID TYPE, HIGH NUCLEAR GRADE. D. THE DUCTAL CARCINOMA IN SITU EXTENDS CLOSE (<0.1CM) TO THE POSTERIOR SURGICAL MARGIN. OF RECECTION. E. ALL SURGICAL MARGINS OF RESECTION ARE FREE OF TUMOR. F. NON-NEOPLASTIC BREAST WITH FIBROCYTIC CHANGES. PART 2: SENTINEL LYMPH NODE #1, RIGHT AXILLA, BIOPSY -. ONE (1) LYMPH NODE, NEGATIVE FOR TUMOR (0/1), (see comment). PART 3: SENTINEL LYMPH NODE #2, RIGHT AXILLA, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR TUMOR, (0/1), (see comment). PART 4: NON-SENTINEL LYMPH NODE, RIGHT AXILLA, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR TUMOR, (0/1). COMMENT: Cytokeratin (AE1/3) stains have been performed and confirm the negative status of the sentinal lymph nodes.

expanded version (tokens=981) : 
 Histological classification: Infiltrating ductal carcinoma, separate foci of ductal carcinoma in situ solid type, high nuclear grade.

Subtype: Basal

Necrosis: No mention of necrosis in the report.

Tumor infiltrating lymphocytes: No mention of tumor infiltrating lymphocytes in the report.

Histological grade: Poorly differentiated, Nottingham score - 9/9 (tubules = 3, nuclear grade = 3, mitoses = 3).

Nuclear grade: High nuclear grade in the separate foci of ductal carcinoma in situ.

Lymphovascular invasion: Lymphovascular invasion identified.

Calcification: No mention of calcifications in the report.

Receptor status: HER-2/NEU weakly positive (score 2+). ER and PR results not provided yet; to be reported subsequently.

Ancillary testing results: Cytokeratin (AE1/3) stains confirm negative status of the sentinel lymph nodes.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1140) : 
 Pathology report revealed a 3.1 cm poorly differentiated basal subtype infiltrating ductal carcinoma with high nuclear grade separate foci of solid-type ductal carcinoma in situ close to the posterior surgical margin of resection. Lymphovascular invasion was identified, and HER-2/NEU was weakly positive (score 2+). ER and PR results were not reported yet. One sentinel lymph node and one non-sentinel lymph node biopsies were negative for tumor cells confirmed by cytokeratin (AE1/3) staining.

